The interaction of factor VIIa with rehydrated, lyophilized platelets

References

• Hedner U, Glazer S, Pingel K, et al. (Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193
   PubMed Web of Science ®Google Scholar
• Hedner U. Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis 1990; 1: 307–317
   PubMedGoogle Scholar
• Poon M-C, Demers C, Jobin F, Wu JWY. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann Thrombasthenia. Blood 1999; 94: 3951–3953
   PubMed Web of Science ®Google Scholar
• Kristensen J, Killander A, Hippe E, et al. (Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26(Suppl 1)159–164
   PubMedGoogle Scholar
• Poon MC, d'Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000; 11(Suppl 1)S55–68
   PubMed Web of Science ®Google Scholar
• Tanaka KA, Waly AA, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 2003; 98: 1513–1515
   PubMed Web of Science ®Google Scholar
• Monroe DM, Hoffman M, Oliver JA, Roberts HR. A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis 1998; 9(Suppl 1)S15–20
   PubMedGoogle Scholar
• Monroe D, Hoffman M, Allen M, Roberst H. The factor VII-platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopenia. Sem Thromb Hemo 2000; 26: 373–377
   PubMed Web of Science ®Google Scholar
• Gabriel DA, Li X, Monroe DM, 3rd, Roberts HR. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2004; 2: 1816–1822
   PubMed Web of Science ®Google Scholar
• Blatt J, Gold S, Wiley J, Monahan P, Cooper H, Harvey D. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplantation 2001; 28: 405–407
   PubMed Web of Science ®Google Scholar
• Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002; 32(Suppl 1)41–46
   PubMedGoogle Scholar
• Dutton RP, Hess JR, Scalea TM. Recombinant factor viia for control of hemorrhage: Early experience in critically ill trauma patients. J Clin Anesth 2003; 15: 184–188
   PubMed Web of Science ®Google Scholar
• Martinowitz U. The use of rFVIIa as an adjunct treatment for hemorrhage control in trauma and surgery. Bloodline Rev 2001; 1: 9–11
   Google Scholar
• Bode A. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990; 16: 109–126
   PubMedGoogle Scholar
• Blajchman M. Bacterial contamination of blood products and the value of pre-transfusion testing. Immun Invest 1995; 24: 163–170
   PubMed Web of Science ®Google Scholar
• Blajchman M. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol Std 2000; 102: 183–193
   Google Scholar
• Read MS, Reddick RL, Bode AP, et al. (Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci 1995; 92: 397–401
   PubMed Web of Science ®Google Scholar
• Bode A, Read M, Summaria L. Lyophilized platelets: Nearing clinical trials. Platelets 1997; 8: 436–437
   Web of Science ®Google Scholar
• Bode A, Read M, Reddick R. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 1999; 133: 200–211
   PubMed Web of Science ®Google Scholar
• Fischer TH, Khandelwas G, Merricks E, Raymer R, Nichols T, Bode A, Bellinger D, Russel K, Reddick R, Sanders W, et al. (Thrombus formation and lysis with rehydrated, lyophilized platelets. Hematology 2002; 7: 359–369
   PubMedGoogle Scholar
• Fischer TH, Merricks EP, Russell KE, et al. (Intracellular function in rehydrated lyophilized platelets. Br J Haematol 2000; 111: 167–174
   PubMed Web of Science ®Google Scholar
• Bode AaR MS. Lyophilized platelets for transfusion. Platelet therapy: Current status and future challenges, E Seghatchian JaS. Elsevier Sci., Amsterdam 2001; 132–167
   Google Scholar
• Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA 1995; 92: 397–401
   PubMed Web of Science ®Google Scholar
• Fischer TH, Merricks E, Raymer R, Nichols T, Hayes P, Bode A, Pearce L, Manning J. The co-infusion of rehydrated lyopholized platelets wth HBOC-201 for hemostasis in dilutional thrombocytopenia. Blood 2001b; 98: 2250
   Web of Science ®Google Scholar
• Fischer TH, Merricks EP, Bode AP, et al. (Thrombus formation with rehydrated, lyophilized platelets. Hematology 2002; 7: 359–369
   PubMedGoogle Scholar
• Khandelwal G, Sanders W, Bode A, Nichols T, Erickson G, Read M. von Willebrand factor binding to rehydrated lophilized platelet surface GP1b and inhibition by monoclonal antibody to GP1b. FASEB J 1997; 11: 1812
   Web of Science ®Google Scholar
• Fischer TH, Bode AP, Parker BR, et al. (Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets. Transfusion 2006; 46: 1943–1950
   PubMed Web of Science ®Google Scholar
• Bode AP, Hickerson DH. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets 2000; 11: 259–271
   PubMed Web of Science ®Google Scholar
• Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542–547
   PubMed Web of Science ®Google Scholar
• Hagen FS, Gray CL, O'Hara P, et al. (Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci 1986; 83: 2412–2416
   PubMed Web of Science ®Google Scholar
• Soriano-Garcia M, Padmanabhan K, de Vos AM, Tulinsky A. The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992; 31: 2554–2566
   PubMed Web of Science ®Google Scholar
• Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Biochemistry 1995; 34: 12126–12137
   PubMed Web of Science ®Google Scholar
• Ellison EH, Castellino FJ. Adsorption of vitamin K-dependent blood coagulation proteins to spread phospholipid monolayers as determined from combined measurements of the surface pressure and surface protein concentration. Biochemistry 1998; 37: 7997–8003
   PubMed Web of Science ®Google Scholar
• Huang M, Rigby AC, Morelli X, et al. (Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 2003; 10: 751–756
   PubMedGoogle Scholar
• Colman RW, Schmaier AH. The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions. Crit Rev Oncol Hematol 1986; 5: 57–85
   PubMed Web of Science ®Google Scholar
• Fischer TH, Thatte HS, Nichols TC, Bender-Neal DE, Bellinger DA, Vournakis JN. Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber mediated hemostasis. Biomaterials 2005; 26: 5433–5443
   PubMed Web of Science ®Google Scholar
• Valeri CR, Macgregor H, Barnard MR, Summaria L, Michelson AD, Ragno G. In vitro testing of fresh and lyophilized reconstituted human and baboon platelets. Transfusion 2004; 44: 1505–1512
   PubMed Web of Science ®Google Scholar
• Fischer TH, Merricks E, Raymer R, Nichols T, Hayes P, Bode A, Pearce L, Manning J. The co-infusion of rehydrated lyopholized platelets wth HBOC-201 for hemostasis in dilutional thrombocytopenia. Blood 2001; 98: 2250
   Web of Science ®Google Scholar
• Bode AP, Read MS, Reddick RL. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 1999; 133: 200–211
   PubMed Web of Science ®Google Scholar